Search

everythinglearnresearchcommunity

for

Search:↓

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Combining skin tissue pathology with genetics has greatly improved the diagnosis and understanding of certain skin diseases.

Cultured epithelium can form hair follicles when combined with dermal papillae.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Testosterone injections can cause skin darkening and thickening.

Intense pulsed light treatment mainly damages pigmented hair parts but spares stem cells, allowing hair to regrow.

Improving how drugs are absorbed through the skin could better treat mange in wombats.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Understanding fetal skin development helps diagnose congenital skin diseases.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.